266 related articles for article (PubMed ID: 7041131)
41. Stoichiometry and sedimentation properties of the complex formed between the C1q and C1r2C1s2 subcomponents of the first component of complement.
Siegel RC; Schumaker VN; Poon PH
J Immunol; 1981 Dec; 127(6):2447-52. PubMed ID: 6975324
[TBL] [Abstract][Full Text] [Related]
42. Antibody-independent interactions between Escherichia coli J5 and human complement components.
Betz SJ; Isliker H
J Immunol; 1981 Nov; 127(5):1748-54. PubMed ID: 6795260
[TBL] [Abstract][Full Text] [Related]
43. Electron microscopy of the first component of human complement.
Schumaker VN; Strang CJ; Siegel RL; Phillips ML; Poon PH
Surv Immunol Res; 1982; 1(4):305-15. PubMed ID: 6314471
[No Abstract] [Full Text] [Related]
44. Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
Bindon CI; Hale G; Waldmann H
Eur J Immunol; 1988 Oct; 18(10):1507-14. PubMed ID: 2973413
[TBL] [Abstract][Full Text] [Related]
45. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
46. [Activation of complement by mixed cryoglobulin].
Hishitani Y
Nihon Naika Gakkai Zasshi; 1983 Jun; 72(6):745-50. PubMed ID: 6606694
[No Abstract] [Full Text] [Related]
47. Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement.
Wright JK; Tschopp J; Jaton JC; Engel J
Biochem J; 1980 Jun; 187(3):775-80. PubMed ID: 6985362
[TBL] [Abstract][Full Text] [Related]
48. [Correlations between complement degradation products and circulating immune complexes in human glomerulonephritis].
Coppo R; De Marchi M; Alloatti S; Segoloni G; Giacchino F; Quarello F; Roccatello D; Bulzomi MR; Piccoli G
Minerva Nefrol; 1979; 26(3):243-50. PubMed ID: 318057
[No Abstract] [Full Text] [Related]
49. The complement system: physiology, disorders, and activity in the newborn infant.
Johnston RB
Mead Johnson Symp Perinat Dev Med; 1986; (24):7-12. PubMed ID: 2943950
[No Abstract] [Full Text] [Related]
50. A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement.
Ziccardi RJ
J Immunol; 1982 Jun; 128(6):2505-8. PubMed ID: 7077078
[No Abstract] [Full Text] [Related]
51. Activation of a complex of C1r and C1s subcomponents of human complement C1 by the third subcomponent C1q.
Lin TY; Fletcher DS
J Biol Chem; 1980 Aug; 255(16):7756-62. PubMed ID: 6249812
[No Abstract] [Full Text] [Related]
52. FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia.
Hidvégi T; Ermolin GA; Efremov EE; Dikov MM; Kurmanova LV; Vnashenkova GV; Merkulova MV; Kókai M; Panya A; Füst G
Immunol Lett; 1989 Jul; 22(1):1-6. PubMed ID: 2550362
[TBL] [Abstract][Full Text] [Related]
53. Dissociation of C1 and concentration dependence of its activation kinetics.
Kilchherr E; Fuchs H; Tschopp J; Engel J
Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
[TBL] [Abstract][Full Text] [Related]
54. [Biochemical data on C1 intrinsic activation (author's transl)].
Colomb MG; Bensa JC; Villiers CL; Arlaud GJ
Ann Immunol (Paris); 1982; 133C(2):155-64. PubMed ID: 6287903
[TBL] [Abstract][Full Text] [Related]
55. Interaction of purified lipoteichoic acid with the classical complement pathway.
Loos M; Clas F; Fischer W
Infect Immun; 1986 Sep; 53(3):595-9. PubMed ID: 3488963
[TBL] [Abstract][Full Text] [Related]
56. The role of the classical pathway for the bactericidal effect of normal sera against gram-negative bacteria.
Clas F; Schmidt G; Loos M
Curr Top Microbiol Immunol; 1985; 121():19-72. PubMed ID: 3936682
[No Abstract] [Full Text] [Related]
57. Activation of human C1r: Western blot analysis reveals slow and dose-dependent activation.
Hosoi S; Borsos T
J Immunol; 1988 Sep; 141(5):1610-4. PubMed ID: 2842400
[TBL] [Abstract][Full Text] [Related]
58. Antibody-independent activation of the complement system by mitochondria is mediated by cardiolipin.
Peitsch MC; Tschopp J; Kress A; Isliker H
Biochem J; 1988 Jan; 249(2):495-500. PubMed ID: 3277626
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of C1q binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum.
Niven IP; Whaley K
Rheumatol Int; 1986; 6(5):205-8. PubMed ID: 3492025
[TBL] [Abstract][Full Text] [Related]
60. The first component of human complement (C1): activation and control.
Ziccardi RJ
Springer Semin Immunopathol; 1983; 6(2-3):213-30. PubMed ID: 6314572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
